Lead removal to slow kidney decline in diabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This trial tests whether a medication that removes lead from the body can slow the worsening of kidney function in people with type 2 diabetes and kidney disease. It might help if you have higher lead levels in your blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes with kidney disease
- Your blood lead level is 5 micrograms per deciliter or higher
- Your kidney disease is not too advanced (stage 3 or earlier)
- You are 18 years or older
- You do not have high blood pressure or high cholesterol
- You have no history of cancer, autoimmune disease, or past lead exposure at work
- You are not allergic to the study drug (dimercaptosuccinic acid)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment that removes lead from the blood to see if it can help slow down kidney damage in people with type 2 diabetes. It may be an option for those with higher lead levels and early-stage kidney disease.
This study tests whether taking a lactoferrin supplement can help people with type 2 diabetes and chronic kidney disease (stage 3 or 4) by reducing protein in their urine, which is a sign of kidney damage. It may offer a new way to slow the progression of kidney disease.
This Phase 2 study tests whether adding NAD can improve kidney health in people with diabetes-related kidney disease. It is designed for people with certain urine lab results showing kidney stress, while keeping blood sugar and safety limits within range.
This trial studies whether a drug called finerenone can safely and effectively treat kidney disease caused by type 2 diabetes. If you qualify, you would take finerenone while your regular diabetes and blood pressure medications continue unchanged.
This trial tests a medication, finerenone, to help protect kidney function and prevent heart failure in people with type 2 diabetes and chronic kidney disease. If you have diabetes and kidney problems, this medicine might slow down further kidney damage.
This study tests an investigational drug called ALN-ANG3 to see if it can help people with diabetic kidney disease. The drug may reduce kidney damage and slow down the loss of kidney function. If you join, you will get the study drug or a placebo (a dummy shot) and be followed by a study doctor.
Hear when a new Type 2 Diabetic Nephropathy With Elevated Blood Lead Burden trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.